Tacalyx
Description: Tacalyx develops cancer therapeutics targeting tumor-specific carbohydrate antigens to treat metastatic tumors with unmet needs.
Country: Germany
Based in: Berlin
Founded: 2019
Funding Stage: Pre-Seed
Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
